Search

Author/Creator Callahan, Margaret K

1. Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, two-stage, multi-arm, phase 1/2 trial. Issue 11 (November 2016)

Authors:
Sharma, Padmanee; Callahan, Margaret K; Bono, Petri; Kim, Joseph; Spiliopoulou, Pavlina; Calvo, Emiliano; Pillai, Rathi N; Ott, Patrick A; de Braud, Filippo; Morse, Michael; Le, Dung T; Jaeger, Dirk; Chan, Emily; Harbison, Chris; Lin, Chen-Sheng; Tschaika, Marina; Azrilevich, Alex; Rosenberg, Jon...
Journal:
Lancet oncology
Issue:
Volume 17:Issue 11(2016:Nov.)
Page Start:
1590
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Peripheral blood and tumor biomarkers in patients with advanced melanoma treated with combination nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab. (7th November 2013)

Authors:
Callahan, Margaret K; Horak, Christine E; Curran, Michael A; Hollman, Travis; Schaer, David A; Yuan, Jianda; Lesokhin, Alexander M; Kitano, Shigehisa; Hong, Quan; Ariyan, Charlotte E; Busam, Klaus J; Feely, William; Jure-Kunkel, Maria; Grosso, Joseph; Simon, Jason S; Korman, Alan J; Wigginton, Jo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors. Issue 8 (8th August 2022)

Authors:
Sanborn, Rachel E; Pishvaian, Michael J; Callahan, Margaret K; Weise, Amy; Sikic, Branimir I; Rahma, Osama; Cho, Daniel C; Rizvi, Naiyer A; Sznol, Mario; Lutzky, Jose; Bauman, Julie E; Bitting, Rhonda L; Starodub, Alexander; Jimeno, Antonio; Reardon, David A; Kaley, Thomas; Iwamoto, Fabio; Baehri...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 8(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. The Current Understanding of the Endocrine Effects From Immune Checkpoint Inhibitors and Recommendations for Management. Issue 3 (19th July 2018)

Authors:
Girotra, Monica; Hansen, Aaron; Farooki, Azeez; Byun, David J; Min, Le; Creelan, Ben C; Callahan, Margaret K; Atkins, Michael B; Sharon, Elad; Antonia, Scott J; West, Pamela; Gravell, Amy E
Journal:
JNCI cancer spectrum
Issue:
Volume 2:Issue 3(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗